Canadian association of radiologists consensus guidelines for the prevention of contrast-induced nephropathy: Update 2012

Canadian Association of Radiologists Journal

Volumn 65, Issue 2, 2014, Pages 96-105

  Owen, Richard J ^a   Hiremath, Swapnil ^b   Myers, Andy ^c   Fraser Hill, Margaret ^b   Barrett, Brendan J ^d  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c Radiology Lakeridge Health   (Canada)

^d MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Acute renal failure; Chronic kidney disease; Contrast induced acute kidney injury; Contrast induced nephropathy; Metformin; N Acetylcysteine

Indexed keywords

ACETYLCYSTEINE; CARBON DIOXIDE; CREATININE; GADOLINIUM; METFORMIN;

ARTICLE; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DEHYDRATION; DIALYSIS; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMOFILTRATION; HIGH RISK PATIENT; HUMAN; INTRAVENOUS ADMINISTRATION; KIDNEY FUNCTION; MEDICAL SOCIETY; NEPHROLOGIST; OUTCOME ASSESSMENT; OUTPATIENT; PRACTICE GUIDELINE; PROPHYLAXIS; RADIOLOGIST; RISK ASSESSMENT;

ACUTE RENAL FAILURE; CHRONIC KIDNEY DISEASE; CONTRAST-INDUCED ACUTE KIDNEY INJURY; CONTRAST-INDUCED NEPHROPATHY; METFORMIN; N-ACETYLCYSTEINE;

CANADA; CONTRAST MEDIA; HUMANS; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; RISK FACTORS; SOCIETIES, MEDICAL;

EID: 84899440447     PISSN: 08465371     EISSN: 14882361     Source Type: Journal    
DOI: 10.1016/j.carj.2012.11.002     Document Type: Article

References (60)

1. S.H. Hou, D.A. Bushinsky, and J.B. Wish Hospital-acquired renal insufficiency: a prospective study Am J Med 74 1983 243 248
2. P.A. McCullough, R. Wolyn, and L.L. Rocher et al. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality Am J Med 103 1997 368 375
3. K. Nash, A. Hafeez, and S. Hou Hospital-acquired renal insufficiency Am J Kidney Dis 39 2002 930 936
4. E.M. Levy, C.M. Viscoli, and R.I. Horwitz The effect of acute renal failure on mortality. A cohort analysis JAMA 275 1996 1489 1494
5. C.S. Rihal, S.C. Textor, and D.E. Grill et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention Circulation 105 2002 2259 2264
6. S.K. Morcos Contrast medium-induced nephrotoxicity P. Dawson, Textbook of Contrast Media 1999 Isis Medical Media Oxford, England
7. A. Benko, M. Fraser-Hill, and P. Magner et al. Canadian Association of Radiologists: consensus guidelines for the prevention of contrast-induced nephropathy Can Assoc Radiol J 58 2007 79 87
8. S.K. Morcos, H.S. Thomsen, and J.A. Webb Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR) Eur Radiol 9 1999 1602 1613
9. M.M. Waybill, and P.N. Waybill Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention J Vasc Interv Radiol 12 2001 3 9
10. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
11. Part 4. Definition and classification of stages of chronic kidney disease Am J Kidney Dis 39 suppl 2002 S46 S75
12. G. Dangas, I. Iakovou, and E. Nikolsky et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables Am J Cardiol 95 2005 13 19
13. M.R. Rudnick, S. Goldfarb, and L. Wexler et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study Kidney Int 47 1995 254 261
14. R.W. Katzberg, and J.H. Newhouse Intravenous contrast medium-induced nephrotoxicity: is the medical risk really as great as we have come to believe? Radiology 256 2010 21 28
15. C.L. Manske, J.M. Sprafka, and J.T. Strony et al. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography Am J Med 89 1990 615 620
16. S.T. Cochran Determination of serum creatinine level prior to administration of radiographic contrast media JAMA 277 1997 517 518
17. R.B. Tippins, W.E. Torres, and B.R. Baumgartner et al. Are screening serum creatinine levels necessary prior to outpatient CT examinations? Radiology 216 2000 481 484
18. B.A. Bartholomew, K.J. Harjai, and S. Dukkipati et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification Am J Cardiol 93 2004 1515 1519
19. R. Mehran, E.D. Aymong, and E. Nikolsky et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation J Am Coll Cardiol 44 2004 1393 1399
20. M.W. Rich, and C.A. Crecelius Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study Arch Intern Med 150 1990 1237 1242
21. H.S. Thomsen, and S.K. Morcos In which patients should serum creatinine be measured before iodinated contrast medium administration? Eur Radiol 15 2005 749 754
22. B.J. Barrett, and P.S. Parfrey Clinical practice. Preventing nephropathy induced by contrast medium N Engl J Med 354 2006 379 386
23. P.L. Choyke, J. Cady, and S.L. DePollar et al. Determination of serum creatinine prior to iodinated contrast media: is it necessary in all patients? Tech Urol 4 1998 65 69
24. J.C. Olsen, and B. Salomon Utility of the creatinine prior to intravenous contrast studies in the emergency department J Emerg Med 14 1996 543 546
25. M.D. Blaufox, M. Aurell, and B. Bubeck et al. Report of the Radionuclides in Nephrourology Committee on renal clearance J Nucl Med 37 1996 1883 1890
26. P.A. McCullough, and S.S. Soman Contrast-induced nephropathy Crit Care Clin 21 2005 261 280
27. R.W. Katzberg, and B.J. Barrett Risk of iodinated contrast material: induced nephropathy with intravenous administration Radiology 243 2007 622 628
28. S.A. Nguyen, P. Suranyi, and J.G. Ravenel et al. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function Radiology 248 2008 97 105
29. S.D. Weisbord, M.K. Mor, and A.L. Resnick et al. Incidence and outcomes of contrast-induced AKI following computed tomography Clin J Am Soc Nephrol 3 2008 1274 1281
30. M.J. Kuhn, N. Chen, and D.V. Sahani et al. The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure AJR Am J Roentgenol 191 2008 151 157
31. H.S. Thomsen, and S.K. Morcos Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT: a pooled analysis of two randomized trials Eur Radiol 19 2009 891 897
32. G.J. Merten, W.P. Burgess, and L.V. Gray et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial JAMA 291 2004 2328 2334
33. S.S. Brar, A.Y. Shen, and M.B. Jorgensen et al. Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial JAMA 300 2008 1038 1046
34. S.S. Brar, S. Hiremath, and G. Dangas et al. Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis Clin J Am Soc Nephrol 4 2009 1584 1592
35. M.A. Stevens, P.A. McCullough, and K.J. Tobin et al. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation J Am Coll Cardiol 33 1999 403 411
36. R.V. Freeman, M. O'Donnell, and D. Share et al. Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose Am J Cardiol 90 2002 1068 1073
37. H.H. Abujudeh, M.S. Gee, and R. Kaewlai In emergency situations, should serum creatinine be checked in all patients before performing second contrast CT examinations within 24 hours? J Am Coll Radiol 6 2009 268 273
38. H.S. Thomsen, S.K. Morcos, and B.J. Barrett Contrast-induced nephropathy: the wheel has turned 360 degrees Acta Radiol 49 2008 646 657
39. H. Trivedi, and W.D. Foley Contrast-induced nephropathy after a second contrast exposure Ren Fail 32 2010 796 801
40. Canadian Pharmacists Association Glucophage. Compendium of Pharmaceuticals and Specialities: The Canadian Drug Reference for Health Professionals Toronto: Canadian Pharmacists Association Webcom Inc, 2009 1027
41. H.S. Thomsen, and S.K. Morcos Contrast media and metformin: guidelines to diminish the risk of lactic acidosis in non-insulin-dependent diabetics after administration of contrast media. ESUR Contrast Media Safety Committee Eur Radiol 9 1999 738 740
42. W.H. Bush, and M. Bettmann Update on metformin (Glucophage) therapy and the risk of lactic acidosis: change in FDA-approved package insert ACR Bulletin 54 1998 15
43. The Royal Australian and New Zealand College of Radiologists Guidelines for Metformin Hydrochloride 2006 The Royal Australian and New Zealand College of Radiologists Available at: http://www.ranzcr.edu.au/resources/professional- documents/guidelines Accessed February 11, 2014
44. G. Marenzi, I. Marana, and G. Lauri et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration N Engl J Med 349 2003 1333 1340
45. D.N. Cruz, M.A. Perazella, and R. Bellomo et al. Extracorporeal blood purification therapies for prevention of radiocontrast-induced nephropathy: a systematic review Am J Kidney Dis 48 2006 361 371
46. H. Reinecke, M. Fobker, and J. Wellmann et al. A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy: the Dialysis-versus-Diuresis (DVD) Trial Clin Res Cardiol 96 2007 130 139
47. P. Aspelin, P. Aubry, and S.G. Fransson et al. Nephrotoxic effects in high-risk patients undergoing angiography N Engl J Med 348 2003 491 499
48. M.C. Heinrich, L. Haberle, and V. Muller et al. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials Radiology 250 2009 68 86
49. R.J. Solomon, M.K. Natarajan, and S. Doucet et al. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease Circulation 115 2007 3189 3196
50. R.S. Wright, J.L. Anderson, and C.D. Adams et al. 2011 ACCF/AHA focused update of the Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons J Am Coll Cardiol 57 2011 215 367
51. U. Nyman, B. Elmstahl, and P. Leander et al. Are gadolinium-based contrast media really safer than iodinated media for digital subtraction angiography in patients with azotemia? Radiology 223 2002 311 318
52. S.E. Cowper Nephrogenic systemic fibrosis: an overview J Am Coll Radiol 5 2008 23 28
53. T. Grobner Gadolinium: a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21 2006 1104 1108
54. M. Tepel, G.M. van Der, and C. Schwarzfeld et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine N Engl J Med 343 2000 180 184
55. C.S. Baker, A. Wragg, and S. Kumar et al. A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study J Am Coll Cardiol 41 2003 2114 2118
56. G. Marenzi, E. Assanelli, and I. Marana et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty N Engl J Med 354 2006 2773 2782
57. H. Thiele, L. Hildebrand, and C. Schirdewahn et al. Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate Percutaneous Coronary Intervention Acute Myocardial Infarction N-ACC) Trial J Am Coll Cardiol 55 2010 2201 2209
58. S.M. Bagshaw, F.A. McAlister, and B.J. Manns et al. Acetylcysteine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence Arch Intern Med 166 2006 161 166
59. U. Hoffmann, M. Fischereder, and B. Kruger et al. The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable J Am Soc Nephrol 15 2004 407 410
60. D.A. Gonzales, K.J. Norsworthy, and S.J. Kern et al. A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity BMC Med 14 2007 32